Roche, Pfiz­er and Gilead lead rep­u­ta­tion rank­ings by pa­tient groups in an­nu­al sur­vey

Pa­tient groups con­tin­ue to hold a most­ly pos­i­tive opin­ion of the phar­ma in­dus­try, with the ma­jor­i­ty of re­spon­dents to a re­cent sur­vey giv­ing it an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.